Stifel Financial Corp Cara Therapeutics, Inc. Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

A detailed history of Stifel Financial Corp transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 332,995 shares of CARA stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
332,995
Previous 443,151 24.86%
Holding current value
$1.55 Million
Previous $115,000 10.43%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.26 - $0.38 $28,640 - $41,859
-110,156 Reduced 24.86%
332,995 $103,000
Q2 2024

Aug 13, 2024
SELL
$0.24 - $0.92 $71,573 - $274,365
-298,223 Reduced 40.23%
443,151 $115,000
Q1 2024

May 13, 2024
BUY
$0.52 - $1.05 $222,724 - $449,731
428,316 Added 136.82%
741,374 $674,000
Q4 2023

Feb 12, 2024
BUY
$0.6 - $1.65 $69,982 - $192,452
116,638 Added 59.38%
313,058 $231,000
Q3 2023

Nov 13, 2023
BUY
$1.67 - $3.33 $28,688 - $57,206
17,179 Added 9.58%
196,420 $329,000
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $153,221 - $267,461
54,142 Added 43.28%
179,241 $507,000
Q1 2023

May 12, 2023
BUY
$4.89 - $12.27 $205,952 - $516,775
42,117 Added 50.75%
125,099 $614,000
Q4 2022

Feb 13, 2023
SELL
$8.88 - $12.77 $55,881 - $80,361
-6,293 Reduced 7.05%
82,982 $891,000
Q3 2022

Nov 14, 2022
BUY
$8.24 - $12.56 $44,380 - $67,648
5,386 Added 6.42%
89,275 $836,000
Q2 2022

Aug 15, 2022
SELL
$7.45 - $13.84 $10,325 - $19,182
-1,386 Reduced 1.63%
83,889 $766,000
Q1 2022

May 13, 2022
BUY
$9.94 - $12.65 $258,797 - $329,355
26,036 Added 43.95%
85,275 $1.04 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $341,511 - $516,681
-28,483 Reduced 32.47%
59,239 $722,000
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $3,187 - $4,432
-276 Reduced 0.31%
87,722 $1.36 Million
Q2 2021

Aug 13, 2021
SELL
$12.38 - $29.19 $31,073 - $73,266
-2,510 Reduced 2.77%
87,998 $1.26 Million
Q1 2021

May 14, 2021
SELL
$15.07 - $21.71 $17,842 - $25,704
-1,184 Reduced 1.29%
90,508 $1.97 Million
Q4 2020

Feb 12, 2021
BUY
$12.72 - $16.16 $53,016 - $67,354
4,168 Added 4.76%
91,692 $1.39 Million
Q3 2020

Nov 16, 2020
SELL
$12.34 - $17.92 $12,093 - $17,561
-980 Reduced 1.11%
87,524 $1.11 Million
Q2 2020

Aug 14, 2020
BUY
$12.39 - $17.33 $28,633 - $40,049
2,311 Added 2.68%
88,504 $1.51 Million
Q1 2020

May 14, 2020
BUY
$9.12 - $17.78 $209,668 - $408,762
22,990 Added 36.37%
86,193 $1.14 Million
Q4 2019

Feb 13, 2020
BUY
$16.11 - $25.98 $167,785 - $270,581
10,415 Added 19.73%
63,203 $1.02 Million
Q3 2019

Nov 13, 2019
BUY
$18.28 - $26.91 $87,067 - $128,172
4,763 Added 9.92%
52,788 $964,000
Q2 2019

Aug 14, 2019
BUY
$17.68 - $21.57 $257,155 - $313,735
14,545 Added 43.44%
48,025 $1.04 Million
Q1 2019

May 14, 2019
SELL
$14.41 - $19.64 $13,473 - $18,363
-935 Reduced 2.72%
33,480 $656,000
Q4 2018

Feb 13, 2019
BUY
$12.45 - $23.47 $156,185 - $294,431
12,545 Added 57.36%
34,415 $449,000
Q3 2018

Nov 13, 2018
SELL
$17.57 - $23.95 $11,156 - $15,208
-635 Reduced 2.82%
21,870 $525,000
Q2 2018

Aug 14, 2018
SELL
$11.6 - $19.27 $65,192 - $108,297
-5,620 Reduced 19.98%
22,505 $432,000
Q1 2018

May 11, 2018
SELL
$11.77 - $16.08 $128,763 - $175,915
-10,940 Reduced 28.0%
28,125 $347,000
Q4 2017

Feb 14, 2018
SELL
$11.86 - $14.08 $300,473 - $356,716
-25,335 Reduced 39.34%
39,065 $476,000
Q3 2017

Nov 13, 2017
BUY
$12.6 - $16.34 $811,440 - $1.05 Million
64,400
64,400 $0

Others Institutions Holding CARA

# of Institutions
73
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $250M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email